Viewing nowCombinationTelmisartan and Amlodipine Tablets 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
K.S. Pharmaceuticals Co., Ltd.

MFDS item code 201906299 · Approved 2019.09.04 · Insurance code 059000330
Treatment of essential hypertension not controlled with monotherapy
This medication is used to assist effective blood pressure control in patients with essential hypertension whose blood pressure is not well controlled by monotherapy with either telmisartan or amlodipine alone. It helps reduce the risk of complications from hypertension and improves overall cardiovascular health. In other words, this medication is used for blood pressure management in patients with essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before treatment with this medicine. However, a direct switch to this medicine may be considered if blood pressure is not controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Use with caution in the following patients’). In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication must not be used during pregnancy as it can cause serious harm to the fetus, particularly in the second and third trimesters. If pregnancy is confirmed, this medication should be discontinued as soon as possible. The medication should not be used in individuals allergic to its components, in pregnant women or women who may become pregnant, in nursing mothers, in patients with severe liver or biliary disorders, in patients with very weak heart function, in patients with severe hypotension, in patients in cardiogenic shock, or in patients with unstable heart failure after myocardial infarction. Extra caution and possible dosage adjustments are necessary for patients with poor liver function, gastrointestinal diseases, renal vascular issues, renal failure, elderly patients, etc. Common side effects may include dizziness or peripheral edema, and serious side effects can occur rarely, so if any unusual symptoms arise, immediate consultation with a healthcare professional is necessary. This medication should not be used during pregnancy and should preferably not be taken while nursing. The safety and efficacy of this medication in children under 18 have not been sufficiently established, and its use is not recommended. In case of overdose, symptoms such as hypotension, arrhythmia, and decreased kidney function may occur, so immediate medical attention is required. This medicine may interact with other drugs, so any concurrent medications should be disclosed to a doctor or pharmacist. Caution is advised when driving or operating dangerous machinery as dizziness or drowsiness may occur. Store in a place out of reach of children, and it is advisable to open the product packaging only just before use.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a sealed container that can block light, maintaining a temperature between 1 to 30 degrees Celsius at room temperature. This will help to preserve the medication's efficacy and safety over time.
White and light gray, double convex, oval-shaped tablet
30 tablets/box [10 tablets/Alu-Alu X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
K.S. Pharmaceuticals Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.